About this episode
A new meta-analysis of 174 randomized controlled trials on “carbohydrate-restricted diets” found consistent benefits for body composition, blood pressure, inflammation, and more. But instead of highlighting the metabolic benefits, most of the headlines focused almost entirely on a small bump in LDL.In this video, Dr. Bret Scher breaks down why that reaction misses the point and how biases in nutrition reporting are holding back real progress in improving metabolic health.📌In this video, you’ll learn:How the authors classified “carbohydrate-restricted diets”The many health benefits associated with restricting carbohydratesWhat impact low carbohydrate diets had on LDL levelsWhether or not we should sound the alarm on LDL increasesThe double standard in how we talk about diet vs. diabetes drugs that may produce increases in LDLWhat matters more than LDL alone when assessing metabolic riskWhether you're a patient or a practitioner, it’s essential to look beyond sensational headlines and focus on the full body of evidence, especially when it comes to nutrition and cardiovascular risk. Clear and balanced conversations are more important than ever if we want to turn the tide on metabolic disease.🔎 Have questions about how to apply metabolic therapies effectively? Submit them at metabolicmind.org/questions to be featured in a future Metabolic Mailbag episode.👉 Subscribe to Metabolic Mind to stay up-to-date on the latest in metabolic psychiatry, low-carb nutrition, and brain health: https://www.youtube.com/@metabolicmind.#MetabolicMind #KetogenicTherapy #MetabolicDiseaseExpert Featured:Dr. Bret ScherBaszucki Group Medical Directorhttps://x.com/bschermdResources Mentioned:Effects of carbohydrate-restricted diets and macronutrient replacements on cardiovascular health and body composition in adults: a meta-analysis of randomized trials
